Corticosteroid Compositions - EP3574914

The patent EP3574914 was granted to Meritage Pharma on Dec 29, 2021. The application was originally filed on Nov 12, 2008 under application number EP19165329A. The patent is currently recorded with a legal status of "Revoked".

EP3574914

MERITAGE PHARMA
Application Number
EP19165329A
Filing Date
Nov 12, 2008
Status
Revoked
Jun 2, 2023
Grant Date
Dec 29, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DR FALK PHARMASep 1, 2022ADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS6291445
DESCRIPTIONUS6686346
DESCRIPTIONUS6986904
DESCRIPTIONWO2008070129
OPPOSITIONEP1310243
OPPOSITIONUS2007111978
OPPOSITIONWO2009064457
SEARCHUS2007111978
SEARCHUS6598603

Non-Patent Literature (NPL) Citations (49) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ACEVES et al., Am J Gastroenterol., (20071000), vol. 102, no. 10, pages 2271 - 9-
DESCRIPTION- ACEVES S; NEWBURY, RO; DOHIL R; SCHWIMMER J; BASTIAN J, "Distinguishing Eosinophilic Esophagitis in pediatric patients: clinical, endoscopic, and histologic features of an emerging disorder", Journal of Clinical Gastroenterology, (20060000), vol. 41, no. 3, pages 252 - 6-
DESCRIPTION- ACEVES, SS; BASTIAN JF; NEWBURY, RO; DOHIL, R., "Oral viscous budesonide: A potential new therapy for eosinophilic esophagitis", Amer. Journal of Gastroenterology, (20070000), vol. 102, pages 1 - 9-
DESCRIPTION- BUDIN C; VILLARD-TRUC F; RIVET C et al., "Eosinophilic esophagitis: 3 case reports", Gastroenterol. Clin. Biol., (20050000), vol. 29, pages 73 - 5-
DESCRIPTION- CHERIAN S; SMITH N M; FORBES D A, "Rapidly increasing prevalence of eosinophilic oesophagitis in Western Australia", Arch. Dis. Child, (20060000), vol. 91, pages 1000 - 4-
DESCRIPTION- CHEUNG K M; OLIVER M R; CAMERON D J et al., "Esophageal eosinophilia in children with dysphagia", J. Pediatr. Gastroenterol. Nutr., (20030000), vol. 37, pages 498 - 503-
DESCRIPTION- CROESE J; FAIRLEY S K; MASSON J W et al., "Clinical and endoscopic features of eosinophilic esophagitis in adults", Gastrointest. Endosc., (20030000), vol. 58, pages 516 - 22-
DESCRIPTION- FOGG M I; RUCHELLI E; SPERGEL J M, "Pollen and eosinophilic esophagitis", J. Allergy Clin. Immunol., (20030000), vol. 112, pages 796 - 7-
DESCRIPTION- FOX V L; NURKO S; FURUTA G T, "Eosinophilic esophagitis: it's not just kid's stuff", Gastrointest. Endosc., (20020000), vol. 56, pages 260 - 70-
DESCRIPTION- GARRETT J K; JAMESON S C; THOMSON B; COLLINS M H; WAGONER L E; FREESE, D K et al., "Anti-tnterleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes", J. Allergy Clin. Immunol, (20040000), vol. 113, pages 115 - 9-
DESCRIPTION- GUAJARDO J R; PLOTNICK L M; FENDE J M, "Eosinophil-associated gastrointestinal disorders: a world-wide-web based registry", J. Pediatr, (20020000), vol. 141, pages 576 - 81-
DESCRIPTION- LIACOURAS C A; RUCBELLI E, Eosinophilic esophagitis. Cuff. Opin. Pediatr., (20040000), vol. 16, pages 560 - 6-
DESCRIPTION- LIACOURAS C A; WENNER W J; BROWN K; RUCHELLI E, "Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids", J. Pediatr. Gastroenterol. Nutr., (19980000), vol. 26, pages 380 - 5-
DESCRIPTION- MUELLER S; AIGNER T; NEUREITER D; STOLTE M, "Eosinophil infiltration and degranulation in oesophageal mucosa from adult patients with eosinophilic oesophagitis: a retrospective comparative study on pathologic biopsy", J. Clin. Pathol., (20060000), vol. 59, pages 1175 - 80-
DESCRIPTION- NOEL R J; PUTNAM P E; ROTHENBERG M E, "Eosinophilic esophagitis", N. Eng!. J. Med, (20040000), vol. 351, pages 940 - 1-
DESCRIPTION- ORENSTEIN S R; SHALABY T M; DI LORENZO C et al., "The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children", Am. J. Gastroenterol., (20000000), vol. 95, pages 1422 - 30-
DESCRIPTION- PARFITT J R; GREGOR J C; SUSKIN N G, "Eosinophilic esophagitis in adults: distinguishing features from gastroesophageal reflux disease: a study of 41 patients", Mod. Pathol., (20060000), vol. 19, pages 90 - 6-
DESCRIPTION- PLAZA-MARTIN, AM; JIMENEZ-FEIJOO R; ANDALUZ C; GINER-MUNOZ MT; MARTIN-MATEOS MA; PIQUER-GIBERT M; SIERRA-MARTINEZ JI, "Polysensitization to aeroallergens and food in eosinophilic esophagitis in a pediatric population", Alergol. Immunopathol., (20070000), vol. 35, pages 35 - 7-
DESCRIPTION- RAVELLI A M; VILLANACCI V; RUZZENENTI N et al., "Dilated Intercellular Spaces: A Major Morphological Feature of Esophagitis", J. Pediatr. Gastroenterol. Nutr., (20060000), vol. 42, pages 510 - 515-
DESCRIPTION- ROTHENBERG M E, "Eosinophilic gastrointestinal disorders", J. Allergy Clin. Immunol., (20040000), vol. 113, pages 11 - 28-
DESCRIPTION- ROTHENBERG M E; MISHRA A; COLLINS M H; PUTNAM P E, "Pathogenesis and clinical features of eosinophilic esophagitis", J. Allergy Clin. Immunol., (20010000), vol. 108, pages 891 - 4-
DESCRIPTION- RUCHELLI E; WENNER W; VOYTEK T et al., "Severity of esophageal eosinophilia predicts response to conventional gastroesophageal reflux therapy", Pediatr. Dev. Pathol., (19990000), vol. 2, pages 15 - 8-
DESCRIPTION- SANT'ANNA A M; ROLLAND S; FOUMET J C et al., "Eosinophilic Esophagitis in Children: Symptoms, Histology and pH Probe Results", J. Pediatr. Gastroenterol. Nutr., (20040000), vol. 39, pages 373 - 377-
DESCRIPTION- SPERGEL J M; ANDREWS T; BROWN-WHITEHOM T F et al., "Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests", Ann. Allergy Asthma Immunol., (20050000), vol. 95, pages 336 - 43, XP026959325-
DESCRIPTION- SPERGEL J M; BEAUSOLEIL J L; MASCARENHAS M; LIACOURAS C A, "The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis", J. Allergy Clin. Immunol., (20020000), vol. 109, pages 363 - 8-
DESCRIPTION- SPERGEL JM, "Eosinophilic esophagitis in adults and children: evidence for a food allergy component in many patients", Curr. Opin. Allergy Clin. Immunol., (20070000), vol. 7, pages 274 - 8-
DESCRIPTION- STEINER S J; GUPTA S K; CROFFIE J M; FITZGERALD J F, "Correlation between number of eosinophils and reflux index on same day esophageal biopsy and 24 hour esophageal pH monitoring", Am. J. Gastroenterol., (20040000), vol. 99, pages 801 - 5-
DESCRIPTION- STEINER S J; KEMEK K M; FITZGERALD J F, "Severity of Basal Cell Hyperplasia Differs in Reflux Versus Eosinophilic Esophagitis", J. Pediatr. Gastroenterol. Nutr., (20060000), vol. 42, pages 506 - 509-
DESCRIPTION- KELLY K J; LAZENBY A J; ROWE P C et al., "Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula", Gastroenterology, (19950000), vol. 109, doi:doi:10.1016/0016-5085(95)90637-1, pages 1503 - 12, XP002672378
DESCRIPTION- KAGALWALLA A F; SENTONGO T A; RITZ S et al., "Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis", Clin. Gastroenterol. Hepatol., (20060000), vol. 4, doi:doi:10.1016/j.cgh.2006.05.026, pages 1097 - 102, XP005631216
DESCRIPTION- REMEDIOS M; CAMPBELL C; JONES D M; KERLIN P, "Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate", Gastrointest. Endosc., (20060000), vol. 63, doi:doi:10.1016/j.gie.2005.07.049, pages 3 - 12, XP005218952
DESCRIPTION- STRAUMANN A; SIMON H U., "Eosinophilic esophagitis: escalating epidemiology?", J, Allergy Clin. Immunol., (20050000), vol. 115, doi:doi:10.1016/j.jaci.2004.11.006, pages 418 - 9, XP004775701
DESCRIPTION- ACEVES S S; DOHIL R; NEWBURY R O; BASTIAN J F., "Topical viscous budesonide suspension for treatment of eosinophilic esophagitis", J. Allergy Clin. Immunol., (20050000), vol. 116, doi:doi:10.1016/j.jaci.2005.05.011, pages 705 - 6, XP005068207
DESCRIPTION- NICOLAZZO, JA; REED, BL; FINNIN, BC, "Buccal penetration enhancers - how do they really work?", J. Controlled Release, (20050000), vol. 105, doi:doi:10.1016/j.jconrel.2005.01.024, pages 1 - 15, XP004933076
DESCRIPTION- MARKOWITZ J E; SPERGEL J M; RUCHELLI E; LIACOURAS C A, "Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents", Am. J. Gastroenterol., (20030000), vol. 98, doi:doi:10.1016/S0002-9270(03)00054-6, pages 777 - 82, XP002672379
DESCRIPTION- POTTER J W; SAEIAN K; STAFF D et al., "Eosinophilic esophagitis in adults: an emerging problem with unique esophageal features", Gastrointest. Endosc., (20040000), vol. 59, doi:doi:10.1016/S0016-5107(03)02713-5, pages 355 - 61, XP004854169
DESCRIPTION- DESAI T K; STECEVIC V; CHANG C H et al., "Association of eosinophilic inflammation with esophageal food impaction in adults", Gastrointest. Endosc., (20050000), vol. 61, doi:doi:10.1016/S0016-5107(05)00313-5, pages 795 - 801, XP005284895
DESCRIPTION- NOEL R J; PUTNAM P E; COLLINS M H et al., "Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis", Clin. Gastroenterol. Hepatol., (20040000), vol. 2, doi:doi:10.1016/S1542-3565(04)00240-X, pages 568 - 75, XP005120581
DESCRIPTION- LIACOURAS C A; SPERGEL J M; RUCHELLI E, "Eosinophilic esophagitis: a 10-year experience in 381 children", Clin. Gastroenterol. Hepatol., (20050000), vol. 3, doi:doi:10.1016/S1542-3565(05)00885-2, pages 1198 - 206, XP005209103
DESCRIPTION- TEITELBAUM J E; FOX V L; TWAROG F J et al., "Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate", Gastroenterology, (20020000), vol. 122, doi:doi:10.1053/gast.2002.32998, pages 1216 - 25, XP005906823
DESCRIPTION- STRAUMANN A; SPICHTIN H P; GRIZE L et al., "Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 115 years", Gastroenterology, (20030000), vol. 125, doi:doi:10.1053/j.gastro.2003.09.024, pages 1660 - 9, XP005313646
DESCRIPTION- FURUTA, GT; LIACOURAS, CA; COLLINS, MH; SANDEEP, KG; JUSTINICH, C; PUTNAM, PE; BONIS, P; HASSALL, E; STRAUMANN, A; ROTHENBERG, ME, "Eosiniophilic esophagitis in children and adults: A systematic review and consensus recommendations for diagnosis and treatment", Gastroenterology, (20070000), vol. 133, doi:doi:10.1053/j.gastro.2007.08.017, pages 1342 - 1363, XP022271824
DESCRIPTION- DOHIL R; NEWBURY R 0; SELLERS Z M et al., "The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine", J. Pediatr., (20030000), vol. 14, doi:doi:10.1067/S0022-3476(03)00281-6, pages 224 - 30, XP009132048
DESCRIPTION- FAUBION W A, JR.; PERRAULT J; BURGART L J et al., "Treatment of eosinophilic esophagitis with inhaled corticosteroids", J. Pediatr. Gastroenterot. Nutr., (19980000), vol. 27, doi:doi:10.1097/00005176-199807000-00016, pages 90 - 3, XP009070713
DESCRIPTION- LIACOURAS C A., "Eosinophilic esophagitis: treatment in 2005", Curr. Opin. Gastroenterol., (20060000), vol. 22, doi:doi:10.1097/01.mog.0000203863.40632.ba, pages 147 - 152, XP091494953
DESCRIPTION- MISHRA A; HOGAN S P; BRANDT E B; ROTHENBERG M E, "An etiological role for aeroaUergens and eosinophils in experimental esophagitis", J. Clin. Invest., (20010000), vol. 107, doi:doi:10.1172/JCI10224, pages 83 - 90, XP002393729
OPPOSITION- Anonymous, "Avicel® RC-591", Produktbroschüre der FMC Corporation, (19940101), XP055960666-
OPPOSITION- HERAUSG. A. KATDARE et al., "Excipients for Oral Liquid Formulations", Excipient Development for Pharmaceutical, Biotechnology and Drug Delivery Systems, Boca Raton, USA, (20060000), pages 155 - 180, XP055667826-
SEARCH- S Freers, "Maltodextrin", Handbook of Pharmaceutical Excipients - Fifth Edition, UK / USA, Pharmaceutical Press, (20060101), pages 442 - 444, ISBN 978-0-85-369618-6, XP055075444 [A] 1-15 * Monography part 7 *-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents